Total Synthesis of (+)-Pleuromutilin - Journal of the American

Jan 11, 2018 - An 18-step synthesis of the antibiotic (+)-pleuromutilin is disclosed. The key steps of the synthesis include a highly stereoselective ...
0 downloads 25 Views 611KB Size
Subscriber access provided by READING UNIV

Communication

Total Synthesis of (+)-Pleuromutilin Elliot P Farney, Sean S. Feng, Felix Schäfers, and Sarah E. Reisman J. Am. Chem. Soc., Just Accepted Manuscript • DOI: 10.1021/jacs.7b13260 • Publication Date (Web): 11 Jan 2018 Downloaded from http://pubs.acs.org on January 11, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of the American Chemical Society is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society

Total Synthesis of (+)-Pleuromutilin Elliot P. Farney,† Sean S. Feng,† Felix Schäfers, and Sarah E. Reisman* The Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, United States.

Supporting Information Placeholder ABSTRACT: An 18-step synthesis of the antibiotic (+)pleuromutilin is disclosed. The key steps of the synthesis include a highly stereoselective SmI2-mediated cyclization to establish the eight-membered ring, and a stereospecific transannular [1,5]-hydrogen atom transfer to set the C10 stereocenter. This strategy was also used to prepare (+)-12epi-pleuromutilin. The chemistry described here will enable efforts to prepare new mutilin antibiotics.

(+)-Pleuromutilin (1) is a diterpene natural product first isolated from the fungus Clitopilus passeckerianus in 1951 (Scheme 1).1 (+)-Pleuromutilin binds to the peptidyl transferase center of bacterial ribosomes, preventing protein synthesis.2 Semi-synthetic derivatives of 1 in which the C14 ester is modified have been identified as potent antibiotics; for example, retapamulin is an FDA-approved topical antibiotic.3 Recently, derivatives of 12-epi-mutilin have been developed as broad-spectrum antibiotics with efficacy against gramnegative pathogens.4 Given its promising antibacterial properties, four total syntheses of 1 have been reported to date, the most recent of which was disclosed by Herzon and coworkers in 2017.5,6,7 Here we report an approach that enables the preparation of (+)-pleuromutilin and (+)-12-epipleuromutilin in 18 steps from (+)-trans-dihydrocarvone. In considering a design plan for a synthesis of (+)-1, we targeted a modular approach in which a bifunctional hydrindane fragment (e.g. 5) would be annulated to form the eightmembered ring through two sequential C–C bond forming steps. In particular, the C5–C14 and C11–C12 bonds, which each link vicinal stereogenic centers, were identified as strategic points of disconnection. Applying this general plan in a retrosynthesis, (+)-1 was simplified to 2, which was further disconnected through the C5–C14 bond to aldehyde 3 (Scheme 1). In the forward sense, we envisioned forming the eight-membered ring through a late-stage SmI2-mediated ketyl radical cyclization of 3.8 It is important to distinguish this approach from the SmI2-mediated cascade cyclization employed in Procter’s

synthesis of 1,5c,d which formed the C3–C4 bond by a ketyl radical conjugate addition, and the C5–C14 bond—and 8membered ring—by intramolecular aldol cyclization. To enable the cascade reaction, Proctor employed an ester as a precursor to the C15 methyl, and required several additional steps to adjust the oxidation states at C3 and C15. In contrast, a SmI2 cyclization of 3 was expected to provide 2 with C3, C14, and C15 in the correct oxidation states for advancement to 1. Aldehyde 3 was anticipated to arise from enone 4, which, depending on the targeted stereochemistry at C12, could be prepared by crotylation of enal 5 with either Z- or E-boronic Scheme 1. Retrosynthetic analysis. OH

Me

Me

OH

11

Me

mutilin: R = H retapamulin: R =

Me 12

H

O

OH

Me O

Me

S

Me 14 H Me O R

O

O NMe

pleuromutilin (1) O R1 HO 12 11

R1 PO

R2

OH

HH

Me 9 14

O Me

5

Me

5

6

Me

15

3

O 1: R1 = Me, R2 = vinyl 12-epi-1: R1 = vinyl, R2 = Me

R2

SmI2

H OH Me

14

O

R1 PO

R2

O Me

2

3

O

O

Me

strategy: modular fragment coupling to prepare 1 or 12-epi-1

O

R1 HO 12

H

crotylation

9

11

R2

Me

6

Me O

O

5

Me

+

OTrt

R4

Me

R3 Z-6: Me, CH2CH2OTrt E-6: R3 = CH2CH2OTrt, R4 = Me (HO)2B

7

R3 =

R4 =

4 Me

O

Comparison of SmI2 Approaches to Pleuromutilin Framework Me PO

OPiv Procter et al.: 8-membered ring formed by aldol

O 3

SmIIIO

Cyclization product has C3 and C15 at Me incorrect oxidation states

– δ+ δ CO Me 2

15

ACS Paragon Plus Environment

This Work: 8-membered ring formed by ketyl addition

OSmIII 3

O

δ– δ+ Me 15

Me

Cyclization product has C3 and C15 at correct oxidation states

Journal of the American Chemical Society 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 5

Scheme 2. Synthesis of a cyclization substrate. MgBr

O

1)

O

Me

8

3) CuI, THF

CuCN•2LiCl, TMSCl

Me O

7

THF, –45 °C; then 7 2) Pd(OAc)2 (10 mol %) DMSO, O2, rt 91% yield, 2 steps

Me MOMO

Me O

14

O

O O

Me

12) [Cu(MeCN)4]OTf 4-OMebpy, ABNO NMI, MeCN 92% yield

Me –78 °C to –50 °C 4.8:1 dr 71% yield 10

O

O

OTrt

+

12

OTrt

Me

Me Me 13b O 11,12-bis-epi

acid 6.9 Thus, through appropriate design of the crotylation reaction, either 1 or 12-epi-1 would be accessible through this route. Hydrindanone enal 5 was mapped back to enone 7 via sequential conjugate addition reactions and functional group interconversions. The synthesis began with the preparation of enone 7 in one step from (+)-trans-dihydrocarvone.10 Conjugate addition of the cuprate derived from 8, followed by Pd-catalyzed desaturation furnished 9 (Scheme 2). A second conjugate addition furnished the C9-quaternary stereocenter; however, attempts to promote an intramolecular aldol condensation under Brønsted- or Lewis-acid catalysis resulted in the formation of undesired Prins-type products. Hypothesizing that electronic deactivation of the isopropenyl group would mitigate this non-productive reactivity, 10 was converted to the allylic chloride using trichloroisocyanuric acid (TCCA).11 Indeed, treatment of the ketal with HCl at 70 °C provided enone 11 as a 4.4:1 mixture of diastereomers at C6; the major diastereomer was isolated in 52% yield. 1,2-Addition of methylmagnesium chloride was achieved with the aid of CeCl3•2LiCl12 and the diastereomeric mixture was submitted to pyridinium chlorochromate (PCC) to effect an oxidative transposition.13 Kornblum oxidation11 of 12 delivered enal 5 in 8 steps from 7. With enal 5 in hand, the first of two key C–C bond constructions required to form the bridging eight-membered ring was investigated. Reaction of 5 with boronic acid Z-614 under the conditions developed by Szabó and coworkers provided a mixture of diastereomers 13a and 13b (Scheme 4).9b While the reaction proceeded with excellent selectivity for syn crotylation—consistent with a closed transition state—the catalyst did not discriminate between the diasterofaces of the aldehyde during the nucleophilic attack. Use of the S catalyst provides a 1:1.4 mixture of 13a and 13b.15 A brief investigation of alternative catalytic asymmetric crotylation conditions proved unfruitful. Separation of the diastereomers by column chromatography, followed by protection of 13a as the methoxymethyl (MOM) ether, cleavage of the trityl ether, and oxidation under the conditions developed by Stahl16 delivered aldehyde 14.

O

OTrt

O

Me

9) (R)-3,3’-Br2-BINOL (20 mol %)

11

6) CeCl3•2LiCl MeMgCl, 0 °C 7) PCC, CH2Cl2 78% yield, 2 steps

6 Me

11

(HO)2B

Me

Me

desired

5) HCl (aq), THF, 70 °C 4.4:1 dr 52% yield 11

Z-6 HO

13a

Me

O

10

Me HO

O

Cl

4) TCCA, EtOAc, 0 °C 77% yield

9

9

10) MOMCl, iPr2NEt 11) HCO2H, Et2O 70% yield, 2 steps

O

Me MgBr

tBuOH,

3 Å MS PhMe, 0 °C 80% yield 99% brsm 1.2:1 13a:13b

Cl

H

8) KH2PO4, NaI

Me Me O

5

DMSO, 95 ºC 69% yield

Me O

12

Me

At this stage, attention turned to the second key C–C bond construction: a SmI2-mediated cyclization to form the eightmembered ring (Scheme 3). When 14 was treated with a freshly-prepared solution of SmI2 in THF at 0 °C, then quenched with aqueous ammonium chloride, carboxylic acid 16 was obtained as a single diastereomer. Presumably 16 arises from exposure of SmIII-enolate 15 to oxygen, resulting in formation of an a-peroxyketone and subsequent oxidative ring scission.17 Although the ring scission was deleterious, it nonetheless confirmed that C–C bond formation occurred with high diastereoselectivity. In an effort to prevent the unwanted formation of 16, a variety of conditions were evaluated. After substantial optimization, it was found that dropwise addition of SmI2 (3 equiv) to 14 and 6 equiv H2O as a solution in THF at 0 °C, under rigorously anaerobic conditions, followed by quenching first with trimethylsilyl chloride (TMSCl), then aqueous workup delivered tricycle 17 in 93% yield as a separable 23:1 mixture of diastereomers (Scheme 3). The addition of H2O was found to be critical to minimize undesired side-product formation and achieve high diastereoselectivity; reactions conducted in the absence of H2O afforded 17 with 1:1 dr at C14. To complete the synthesis of (+)-1, chemoselective reduction of the C10–C17 exocyclic olefin and installation of the glycolate ester were required. Unfortunately, standard hydrogenation conditions employing cationic transition metal complexes gave rapid and exclusive reduction of the more sterically-accessible C19–C20 vinyl group. Instead, we turned to hydrogen-atom transfer (HAT) reactions, seeking to leverage the thermodynamic preference for formation of a 3°carbon-centered radical.18 Indeed, use of tris(2,2,6,6tetramethyl-3,5-heptanedionato)manganese (III) (Mn(dpm)3) in the presence of phenylsilane and tert-butyl hydroperoxide (TBHP) in degassed, anhydrous isopropanol resulted in highly diastereoselective reduction of the C10– C17 olefin (Scheme 4).19 We were surprised to discover, however, that alkene reduction was accompanied by oxidation of the C14 alcohol. This redox relay process delivered diketone 21 in 55% yield as a single diastereomer. Only

ACS Paragon Plus Environment

Page 3 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society

Scheme 3. Completion of the synthesis of (+)-pleuromutilin (1).

SmI2 conditions Me

14

HH

Me

O Me

Me

O

20

17 10

14

X OH TBHP (2 equiv) iPrOH, rt Me

Me O

Mn(dpm)3 (10 mol %) PhSiH3 (1.5 equiv)

Me MOMO

X H

Me

O Me

17

‡ [Mn]

O

Me MOMO Me

[1,5]-HAT

single Me diastereomer

10 14

X

O Me

3

17) EDCI, DMAP CH2Cl2, rt, 1 h

Me

O 21 X = H, 56% yield X = D, 47% yield >98% D transfer

trace products arising from competing C19-C20 vinyl reduction were observed. Substrates in which the C14 alcohol is protected gave only 6–10% conversion after 6 h, and the resulting C10 stereocenter was formed as a mixture of diastereomers. To test if this reaction proceeds by a transannular [1,5]-HAT process,20 deuterium-labeled substrate 17-d was prepared and exposed to the optimized reaction conditions (Scheme 4). Tricycle 21-d was formed as a single diastereomer with complete transfer of the deuterium label. The observation that substrates in which the C14 alcohol is protected perform poorly under the HAT conditions suggests that cleavage of the O–H bond to form the C14 ketone serves as a driving force for this transformation.21 Having solved the problem of chemoselective alkene reduction, the selective reduction the C14 ketone in the presence of the C3 ketone was now required. Ultimately, selective reduction of diketone 21 proved untenable. Instead, triisopropylsilyl (TIPS) enol ether 18 was prepared and submitted to radical reduction to obtain ketone 19 as a single diastereomer (Scheme 3). To complete the total synthesis, 19 was submitted to excess lithium in ammonia, which furnished alcohol 20 as a separable 14:1 mixture of diastereomers. Subsequent one-pot acylation with 2-(2,2,2trifluoroacetoxy)acetic acid followed by trifluoroacetate methanolysis, then acidic hydrolysis effected global deprotection to deliver (+)-1. A key design aspect of our strategy was the ability to easily vary the stereochemistry of the cyclization substrates at C11

16) Li/NH3 EtOH

HH OH

Me

Et2O, –78 °C 61% yield 14:1 dr

Me

Me Me

18

OTIPS

transannular 15) Mn(dpm)3 redox relay (13 mol %) Me PhSiH3, TBHP iPrOH, rt MOMO 55% yield single H Me O diastereomer

Me MOMO

CO2H

then MeOH Et3N; then Me HCl/THF, 50 °C 80% yield OTIPS 20

Me pleuromutilin (1) O

H OH

THF –78 to 0 °C 76% yield

17

TFAO

OH

Scheme 4. Redox relay by transannular [1,5]-HAT. 19

14

Me

Me HO

16

Me MOMO

14) LiHMDS TIPSOTf

H OH

O

H OH Me O

10

Me

SmI2 (3 equiv) THF, 0 °C, 10 min then NH4Cl (aq) 41% yield

HO2C

19

15

SmIIIO

Me MOMO

20

17

Me

Me

Me MOMO

Me MOMO

H OSmIII then TMSCl (5 equiv) Me 93% yield, 23:1 dr

O

O

rigorously deoxygenated 13) SmI2 (3 equiv) H2O (6 equiv) THF, 0 °C, 5 min

Me MOMO

Me MOMO

Me Me

19

OTIPS

and C12. In particular, given the recent interest in derivatives of C12-epi-mutilin as broad-spectrum antibiotics,4 we sought to demonstrate that the 12-epi-mutilin framework could be prepared. To this end, enal 5 was subjected to crotylation with E-6 under the previously developed conditions, to deliver 13c and 13d as a 2:1 mixture in 85% combined yield (Scheme 5, a). Elaboration of 13c to 12-epi-14 proceeded without difficulty.15 Exposure of 12-epi-14 to the optimal conditions for the SmI2 cyclization furnished 12-epi-17 in Scheme 5. Reactivity of diastereomeric cyclization substrates. (a) Synthesis of 12-epi-1. E-6 Me

O

Me

5

Me

SmI2 (3 equiv) H2O (6 equiv) THF, 0 °C, 5 min

O

11

+

OTrt

Me

Me

Me

13c 12-epi

O

MOMO

O

13d 11-epi

Me

Me H OH Me

then TMSCl (5 equiv) 77% yield, 17:1 dr

Me O

HO OTrt

tBuOH,

3 Å MS PhMe, 0 °C 85% yield 2:1 13c:13d

Me

Me

12

(R)-3,3’-Br2-BINOL (20 mol %)

Me

MOMO

HO

(HO)2B

H

O

Me

OTrt

4 steps

12-epi-1

Me

12-epi-14

O

12-epi-17

(b) Cyclization of a 11,12-bis-epi substrate.

H MOMO

12

MOM

SmI2 (3 equiv) H2O (6 equiv) THF, 0 °C, 5 min

Me

11

O Me

22 Me 11,12-bis-epi SmI2 SET

H

then TMSCl (5 equiv) 20% yield

Me

26

Dowd-Beckwith rearrangement

Me OMOM

Me OMOM

H SmIIIO

H SmIIIO

Me

Me

Me

Me

23

SmI2 SET

Me OMOM

H SmIIIO

O

H

Me

O

O

Me

O

Me O

24

Me O

25

3 ACS Paragon Plus Environment

Journal of the American Chemical Society 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

77% yield and 17:1 dr. 12-epi-17 was smoothly advanced four steps to complete the synthesis of 12-epi-1.15 In contrast, attempts to cyclize aldehyde 22, prepared from crotylation product 13b, revealed that the C11 stereochemistry exerts a pronounced effect on reactivity (Scheme 5, b). Subjection of 22 to the SmI2-mediated cyclization conditions provided tricycle 26 as the major product in 20% yield.22 It is proposed that conformational gearing to minimize A1,2 strain at C11 reverses the regioselectivity of the Sm-ketyl addition to the enone, producing radical 23. Subsequent DowdBeckwith rearrangement proceeding through cyclopropane 24 delivers the product bearing a bridgehead olefin. In summary, the total syntheses of (+)-pleuromutilin and (+)-12-epi-pleuromutilin were each completed in 18 steps (longest linear sequence) from (+)-trans-dihydrocarvone. These syntheses were enabled by a modular approach, which employed a highly diastereoselective SmI2-mediated radical cyclization to form the eight-membered ring. In addition, we uncovered a transannular [1,5]-HAT that effects a stereospecific redox relay to set the C10 stereocenter. The brevity and modularity of the route will enable the design and synthesis of new fully synthetic variants of mutilin antibiotics. ASSOCIATED CONTENT Supporting Information.

The Supporting Information is available free of charge on the ACS Publications website at DOI: xx.xxxx/jacs.xxxxxxxxx. Crystallographic data for 16, 17, and 26 (CIF) Experimental procedures and characterization and spectral data for all compounds (PDF)

AUTHOR INFORMATION Corresponding Author

*[email protected] Author Contributions †

These authors contributed equally to this work.

ACKNOWLEDGMENT We thank Dr. Michael Takase and Larry Henling for X-ray data collection, Ms. Julie Hofstra for X-ray data refinement, Dr. David VanderVelde for assistance with NMR structure determination, Dr. Scott Virgil for assistance with crystallization of 26, and the Caltech 3CS for access to analytical equipment. Fellowship support was provided by the NIH (E.P.F., Grant 1F32GM117764) and NSF (S.S.F., DGE-1144469). Financial support from the Heritage Medical Research Institute is gratefully acknowledged.

REFERENCES

Page 4 of 5

1. (a) Kavanagh, F.; Hervey, A.; Robbins, W. J. Proc. Natl. Acad. Sci. U.S.A. 1951, 37, 570. (b) Birch, A. J.; Holzapfel, C. W.; Rickards, R. W. Tetrahedron 1966, Suppl. 8, Part II, 359. 2. Poulsen, S. M.; Karlsson, M.; Johansson, L. B.; Vester, B. Mol. Microbiol. 2001, 41, 1091-1099. 3. (a) Rittenhouse, S.; Biswas, S.; Broskey, J.; McCloskey, L.; Moore, T.; Vasey, S.; West, J.; Zalacain, M.; Zonis, R.; Payne, D. Antimicrob. Agents. Chemother. 2006, 50, 3882. (b) Fazakerley, N. J.; Procter, D. J. Tetrahedron, 2014, 70, 6911. 4. Thirring, K.; Heilmayer, W.; Riedl, R.; Kollmann, H.; Ivezic-Schoenfeld; Wicha, W.; Paukner, S.; Strickmann, D. WO2015110481A1, 30 July 2015. 5. (a) Gibbons, E. G. J. Am. Chem. Soc. 1982, 104, 1767. (b) Boeckman Jr., R. K.; Springer, D. M.; Alessi, T. R. J. Am. Chem. Soc. 1989, 111, 8284. (c) Helm, M. D.; Da Silva, M.; Sucunza, D.; Findley, T. J. K.; Procter, D. J. Angew. Chem. Int. Ed. 2009, 48, 9315. (d) Fazakerley, N. J.; Helm, M. D.; Procter, D. J. Chem. Eur. J. 2013, 19, 6718. (e)Murphy, S. K.; Zeng, M.; Herzon, S. B. Science 2017, 356, 956. (f) Zeng, M.; Murphy, S. K.; Herzon, S. B. J. Am. Chem. Soc. 2017, 139, 16377. 6. Synthetic studies toward pleuromutilin: (a) Paquette, L. A.; Wiedeman, P. E.; Bulman-Page, P. C. J. Org. Chem. 1988, 53, 1441. (b) Bacque, E.; Pautrat, F.; Zard, S. Org. Lett. 2003, 5, 325. (c) Loresta, S. D.; Liu, J.; Yates, E. V.; Krieger, I.; Sacchettini, J. C.; Freundlich, J. S.; Sorensen, E. J. Chem. Sci. 2011, 2, 1258. 7. For a review of the role of synthesis in antibacterial drug discovery: Wright, P. M; Seiple, I. B.; Myers, A. G. Angew. Chem. Int. Ed. 2014, 53, 8840. 8. For examples of medium size ring construction using SmI2, see: (a) Molander, G. A.; McKie, J. J. Org. Chem. 1994, 59, 3186. (b) Enholm, E. J.; Satici, H.; Trivellas, A. J. Org. Chem. 1989, 54, 5841. (c) Matsuda, F.; Sakai, T.; Okada, N.; Miyashita, M. Tetrahedron Lett. 1998, 39, 863. (d) Molander, G. A.; George, K. M.; Monovich, L. G. J. Org. Chem. 2003, 68, 9533. Blot, V.; Reibig, H.-U. Eur. J. Org. Chem. 2006, 4989. For a review: (e) Edmonds, D. J.; Johnston, D.; Procter, D. J. Chem. Rev. 2004, 104, 3371. 9. (a) Lou, S.; Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660. (b) Alam, R.; Vollgraff, T.; Eriksson, L.; Szabó, K. L. J. Am. Chem. Soc. 2015, 137, 11262. 10. White, J. D.; Grether, U. M.; Lee, C-S. Org. Synth. 2005, 82, 108. Commercially available (+)-dihydrocarvone is supplied as 4:1 mixture of trans and cis isomers, which can be chromatographically separated to give pure trans. 11. Singh, D.; McPhee, D.; Paddon, C. J.; Cherry, J.; Maurya, G.; Mahale, G.; Patel, Y. Kumar, N.; Singh, S.; Sharma, B.; Kushwaha, L.; Singh, S.; Kumar, A. Org. Process Res. Dev. 2017, 21, 551. 12. Krasovskiy, A.; Kopp, F.; Knochel, P. Angew. Chem. Int. Ed. 2006, 45, 497. 13. Dauben, W. G.; Michno, D. M. J. Org. Chem. 1977, 42, 682. 14. See the Supporting Information for the synthesis of Z-6 and E-6. 15. See Supporting Information. 16. Steves, J. E.; Stahl, S. S. J. Am. Chem. Soc. 2013, 135, 15742. 17. This type of oxidative ring scission has previously been observed: Spring, D. M.; Bunker, A.; Luh, B. Y.; Sorenson, M. E.; Goodrich, J. T.; Bronson, J. J.; DenBleyker, K.; Dougherty, T. J.; Fung-Tomc, J. Eur. J. Med. Chem. 2007, 42, 109. 18. (a) Ma, X.; Herzon, S. Chem. Sci. 2015, 6, 6250. (b) Crossely, S. W. M.; Obradors, C.; Martinez, R. M.; Shenvi, R. A. Chem. Rev. 2016, 116, 8912. 19. Conditions were adapted from: Iwasaki, K.; Wan, K. K.; Oppedisano, A.; Crossley, S. W. M.; Shenvi, R. A. J. Am. Chem. Soc. 2014, 136, 1300.

4 ACS Paragon Plus Environment

Page 5 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of the American Chemical Society

20. For examples of transannular [1,5]-HAT on a medium-sized ring, see: (a) Winkler, J. D.; Sridar, V.; Rubo, L.; Hey, J. P.; Haddad, N. J. Org. Chem. 1989, 54, 3004. (b) Boivin, J.; da Silva, E.; Ourisson, G.; Zard, S. Z. Tetrahedron Lett. 1990, 31, 2501. 21. Intermolecular hydrogen-bonding with an acceptor molecule, such as isopropanol solvent, may be responsible for polarizing the O–H bond, leading to weakening of the C14 carbinol hydrogen atom. See: (a) Gawlita, E.; Lantz, M.; Paneth, P.; Bell, A. F.; Tonge, P. J.; Anderson, V. E. J. Am. Chem. Soc. 2000, 122, 11660. (b) Jeffrey, J. L.; Terrett, J. A.; MacMillan, D. W. C. Science 2015, 349, 1532. 22. The aldehyde derived from 13d underwent the analogous cyclization.

TOC graphic: Me HO OH HH

Me

Me

O Me

Me O

O

Me O

(+)-pleuromutilin 18 steps

5 ACS Paragon Plus Environment